Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-23

FDA Approved: SPINRAZA — Original Application (Biogen Inc.)

View source ↗

Summary

FDA approved Spinraza (nusinersen) from Biogen in its original application for spinal muscular atrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spinraza (nusinersen)

Snippet

ORIG AP for SPINRAZA (NUSINERSEN)